Search results - 5 results

The 2021 WHO catalogue of complex mutations associated with drug resistance: A genotypic analysis.

Tuberculosis Abstract: Background: Molecular diagnostics are considered the most promising route to achieving rapid, universal drug susceptibility testing for complex (MTBC). We aimed to generate a WHO endorsed ...

Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases.

drug-resistant TB patients who received M/Clav as part of their treatment from 2009 to 2016 were included. Demographic and clinical data were extracted from medical records. RESULTS: Eighteen XDR- TB patients were ...

Global transcriptional analyses of Mycobacterium tuberculosis using old and new drugs

recent report of the WHO ranks tuberculosis (TB) alongside HIV as a leading cause of death by infectious diseases. In combination, the spread of (multi-)drug resistant Mycobacterium tuberculosis is rising ...

Global transcriptional analyses of Mycobacterium tuberculosis using old and new drugs

ESCMID, Vienna, Austria (2017) Keywords: antibiotics Mycobacterium tuberculosis Transcriptomics Abstract: Background: With 1.5 million deaths in 2014, the most recent report of the WHO ranks tuberculosis ...

RNA-based drug susceptibility testing of Mycobacterium tuberculosis

Background Multidrug resistance of Tuberculosis strains (MDR- TB) are one of the major WHO health concerns. One of the challenges that hampers the effective response to MDR- TB is the long turnaround time of ...

QR code

QR code for this page URL